Correspondence AIDS 2018, 32:531 – 535 Acute hepatitis A breakthrough in MSM in Paris area: implementation of targeted hepatitis A virus vaccine in a context of vaccine shortage The incidence of the hepatitis A virus (HAV) is increasing far lower in HIV-negative MSMs taking PrEP: 61% were in Europe . Sixteen European countries have reported seronegative. Between 25 March and 31 July 2017, all but 1500 cases of conﬁrmed HAVand 2660 cases of probable one HAV seronegative patient who could be contacted or suspected HAV since June 2016: the cases mostly received HAV vaccination. We vaccinated 32 HIV- involved adult MSM. Conﬁrmed cases were related to positive MSMs and 18 MSMs taking PrEP. After the ﬁrst three distinct clusters of genotype IA. In France, increased dose of vaccine, anti-HAV antibodies were found in 85% cases of HAV have been reported within the Paris area of vaccinated individuals. since January 2017 and this outbreak is now spreading to other regions of France . HAV immunization of individuals, including those that had received a ﬁrst dose of vaccine, increased from 76% to In our hospital, 257 HIV-positive MSMs and 31 HIV- 84% in HIV-positive MSMs and from 20 to 89% in
AIDS – Wolters Kluwer Health
Published: Feb 20, 2018
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.
All for just $49/month
It’s easy to organize your research with our built-in tools.
All the latest content is available, no embargo periods.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud